Literature DB >> 26297503

Assessment of Foveal Microstructure and Foveal Lucencies Using Optical Coherence Tomography Radial Scans Following Macular Hole Surgery.

Dilraj S Grewal1, Varun Reddy1, Tamer H Mahmoud2.   

Abstract

PURPOSE: To evaluate the foveal microstructure using high-density (24-line) radial scans and their correlation with visual recovery following macular hole surgery.
DESIGN: Retrospective, consecutive, interventional case series.
METHODS: Forty-five eyes of 43 patients with ≥6 months follow-up following surgery were analyzed. Preoperative predictive measures evaluated included basal hole and minimum linear diameters. Outcome measures included best-corrected visual acuity (BCVA), postoperative foveal lucency horizontal and vertical size, external limiting membrane, and ellipsoid zone defect.
RESULTS: Mean basal hole diameter was 642 ± 330 μm and minimum linear diameter was 277 ± 161 μm. BCVA (logMAR) improved from 0.67 ± 0.23 to 0.31 ± 0.16 at 12 months (P < .001). Foveal lucency horizontal and vertical sizes (μm) improved from 97 ± 81 and 33 ± 18 at 1 month to 26 ± 33 and 19 ± 18, respectively (P < .05) at 12 months. External limiting membrane recovered in all cases at 1 month. Mean ellipsoid zone defect (μm) reduced from 136 ± 164 at 1 month to 32 ± 33 at 12 months (P < .05). Preoperative basal hole diameter correlated with horizontal foveal lucency size at all time points (P < .05). Horizontal foveal lucency size at 1 month correlated (P < .05) with BCVA at 6 and 12 months. Basal hole diameter ≥700 μm (71% sensitivity and 70% specificity) and minimum linear diameter ≥330 μm (71% sensitivity and 70% specificity) were predictive of foveal lucency development. Cataract surgery did not influence foveal lucency resolution and no holes reopened.
CONCLUSION: Using radial scans, 71% of eyes demonstrated a foveal lucency at 1 month, whose size correlated with visual recovery. Preoperative basal hole diameter was predictive of foveal lucency development and size.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26297503     DOI: 10.1016/j.ajo.2015.08.014

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Characteristics of macular microvasculature before and after idiopathic macular hole surgery.

Authors:  Dan Cheng; Ji-Wei Tao; Xue-Ting Yu; Yi-Qi Chen; Mei-Xiao Shen; Min-Hui Wu; Jia-Feng Yu; Heng-Li Lian; Zhe Lu; Li-Jun Shen
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

2.  Preoperative and postoperative features of macular holes on en face imaging and optical coherence tomography angiography.

Authors:  Abtin Shahlaee; Ehsan Rahimy; Jason Hsu; Omesh P Gupta; Allen C Ho
Journal:  Am J Ophthalmol Case Rep       Date:  2016-10-29

3.  Macular hole surgery: an analysis of risk factors for the anatomical and functional outcomes with a special emphasis on the experience of the surgeon.

Authors:  Teresa M Jenisch; Florian Zeman; Michael Koller; David A Märker; Horst Helbig; Wolfgang A Herrmann
Journal:  Clin Ophthalmol       Date:  2017-06-13

4.  Optical coherence tomography angiography features in patients with idiopathic full-thickness macular hole, before and after surgical treatment.

Authors:  Tomasz Wilczyński; Anna Heinke; Agata Niedzielska-Krycia; Daria Jorg; Katarzyna Michalska-Małecka
Journal:  Clin Interv Aging       Date:  2019-03-08       Impact factor: 4.458

5.  Visual Acuity Recovery After Macular Hole Closure Associated With Foveal Avascular Zone Change.

Authors:  Kotaro Tsuboi; Akira Fukutomi; Hirofumi Sasajima; Yuichiro Ishida; Kiichiro Kusaba; Takuya Kataoka; Motohiro Kamei
Journal:  Transl Vis Sci Technol       Date:  2020-07-14       Impact factor: 3.283

6.  Risk factors for glial cell proliferation after idiopathic macular hole repair with internal limiting membrane flap.

Authors:  Yuyan Liu; Changlong Wu; Ying Wang; Yi Dong; Dongqing Liang; Bo Xiao; Quanhong Han; Yanhua Chu
Journal:  BMC Ophthalmol       Date:  2019-12-21       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.